A large-scale retrospective study from Europe showed that the time to local recurrence, time to lymph node recurrence and time to metastasis among HER2-negative BC were similar in ER-low and ER-negative BC and higher compared to ER-high-positive BC [22]. This evidence concerns the gene ERBB2 and breast cancer.